Specialties: Wearable Biosensors/In Vitro Diagnostics/Implantable/Obesity/Diabetes/Infectious Diseases, Weight Loss Device, Continuous Glucose Monitoring Devices, Clinical Trial Design, Clinical Trial Systems, FDA Class III/II/I Medical Devices, PMA /DeNovo/510K, 21CFR820, ISO13485, CLIA Certifications/registrations, Class III, IIb, IIa, I CE Mark Devices (MDD/MDR), Design Control, Early Stage through Post-market Approvals (US and OUS). Commercialization Ramp up, Program Management, Series A through IPO Fund raising